Inogen | INGN - Operating Profit

Stock Price
6.52
Daily Change
0.21 3.33%
Monthly
15.19%
Yearly
-16.52%
Q1 Forecast
5.91

Inogen reported $-7.79M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -9.97M 1.12M Feb/2025
Artivion USD 4.39M 2.12M Sep/2024
AtriCure USD 2.49M 2.28M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Chart Industries USD 177.5M 8M Sep/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Masimo USD 83.9M 300K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Orthofix International USD -84.62M 65.72M Dec/2024
Philips EUR 719M 390M Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
Steris USD 278M 7.1M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
X T L Biopharmaceuticals USD -812K 48K Dec/2024
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025